Statistik Asas
CIK | 1404593 |
SEC Filings
SEC Filings (Chronological Order)
July 11, 2025 |
SUPPLEMENT NO. 2 DATED JULY 10, 2025 TO OFFERING CIRCULAR DATED APRIL 10, 2025 Supplement filed pursuant to Rule 253(g)(2) File No. 024-12484 SUPPLEMENT NO. 2 DATED JULY 10, 2025 TO OFFERING CIRCULAR DATED APRIL 10, 2025 This document supplements, and should be read in conjunction with, the offering circular (the “Offering Circular”) dated April 10, 2025 of Medical Care Technologies, Inc. (the “Company”). Unless otherwise defined in this supplement, capitalized terms used in |
|
July 3, 2025 |
Supplement filed pursuant to Rule 253(g)(2) File No. 024-12484 This document supplements, and should be read in conjunction with, the offering circular (the “Offering Circular”) dated April 10, 2025 of Medical Care Technologies, Inc. (the “Company”). Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circ |
|
April 10, 2025 |
Post-Qualification Offering Circular Amendment No. 3 File No. 024-12484 PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 3 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Circular |
|
April 10, 2025 |
Exhibit 12.1 18305 BISCAYNE BLVD. SUITE 200 JONATHAN D. LEINWAND, P.A. AVENTURA, FL 33160 TEL: (954) 903-7856 FAX: (954) 252-4265 E-MAIL: [email protected] April 9, 2025 Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221 Mesa, AZ 85204 Ladies and Gentlemen: We are acting as counsel to Medical Care Technologies Inc., a Nevada corporation (“MDCE”), for the purpose of rendering an opini |
|
March 27, 2025 |
Post-Qualification Offering Circular Amendment No. 2 File No. 024-12484 PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 2 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Circular |
|
March 14, 2025 |
Post-Qualification Offering Circular Amendment No. 1 File No. 024-12484 PRELIMINARY OFFERING CIRCULAR, POST-QUALIFICATION AMENDMENT NO. 1 SUBJECT TO COMPLETION MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Circular |
|
January 3, 2025 |
Filed pursuant to Rule 253(g)(2) File No. 024-12484 MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 SUPPLEMENT NO. 1 DATED JANUARY 3, 2025 This document supplements, and should be read in conjunction with, the offering circular of Medical Care Technology Inc. (the “Company”), filed with the Securities and Exchange Commission (the “SEC”) pursuant t |
|
December 6, 2024 |
Filed pursuant to Rule 253(g)(1) File No. 024-12484 MEDICAL CARE TECHNOLOGIES, INC. a Nevada Corporation 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Up to 2,000,000,000 Shares of Common Stock Medical Care Technologies Inc., a Nevada corporation (the “Company” or “MDCE”) is offering investors (the “Offering”) the opportunity to purchase MDCE common shares (the “Shares”). The Shares will be sold a |
|
December 4, 2024 |
Medical Care Technologies Inc. 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 Medical Care Technologies Inc. 1910 S Stapley Drive Suite 221 Mesa, AZ 85204 December 4, 2024 Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Medical Care Technologies Inc. Offering Statement on Form 1-A Filed August 9, 2024 File No. 024-12484 To the Staff, This letter sets forth the request of Medical Care Technologies |
|
November 26, 2024 |
PART II — OFFERING CIRCULAR An Offering Circular pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. |
|
September 6, 2024 |
PART II — OFFERING CIRCULAR An Offering Circular pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. |
|
September 6, 2024 |
18305 Biscayne Blvd. SUITE 200 JONATHAN D. LEINWAND, P.A. AVENTURA, FL 33160 TEL: (954) 903-7856 FAX: (954) 252-4265 E-MAIL: [email protected] September 6, 2024 US Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services Washington, D.C. 20549 Re: Medical Care Technologies Inc. Offering Statement on Form 1-A Filed August 9, 2024 File No. 024-12484 Ladies and G |
|
August 9, 2024 |
MEDICAL CARE TECHNOLOGIES INC. SUBSCRIPTION AGREEMENT NOTICE TO INVESTORS Exhibit 4.1 MEDICAL CARE TECHNOLOGIES INC. SUBSCRIPTION AGREEMENT NOTICE TO INVESTORS THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE |
|
August 9, 2024 |
PART II — OFFERING CIRCULAR An Offering Circular pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. |
|
August 9, 2024 |
AMENDED AND RESTATED BYLAWS Medical Care Technologies Inc. Exhibit 2.2 AMENDED AND RESTATED BYLAWS OF Medical Care Technologies Inc. I. SHAREHOLDER'S MEETING. .01 Annual Meetings. The annual meeting of the shareholders of this Corporation, for the purpose of election of Directors and for such other business as may come before it, shall be held at the registered office of the Corporation, or such other places, either within or without the State of Nevada, |
|
August 9, 2024 |
Exhibit 2.1 |
|
August 9, 2024 |
Exhibit 12.1 18305 BISCAYNE BLVD. SUITE 200 JONATHAN D. LEINWAND, P.A. AVENTURA, FL 33160 TEL: (954) 903-7856 FAX: (954) 252-4265 E-MAIL: [email protected] August 8, 2024 Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221 Mesa, AZ 85204 Ladies and Gentlemen: We are acting as counsel to Medical Care Technologies Inc., a Nevada corporation (“MDCE”), for the purpose of rendering an opin |
|
May 8, 2013 |
- FORM 15-12G NOTICE OF TERMINATION FORM 15-12G Notice of Termination UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
April 2, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 Commission File Number 000-53665 CUSIP Number: 584507107 NOTIFICATION OF LATE FILING (Check One) x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2012 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
December 3, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No 1) MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.00001 Per Share (Title of Class of Securities) 584507107 (CUSIP Number) AGS Capital Group, LLC Attn: Allen Silberstein 801 Brickell Avenue, Suite 902 Miami, FL 33131 (305) 789-6641 (Name, Ad |
|
November 20, 2012 |
MEDICAL CARE TECHNOLOGIES INC. ISSUES CEO LETTER TO SHAREHOLDERS Exhibit 99.1 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. ISSUES CEO LETTER TO SHAREHOLDERS Promising future for pediatric healthcare in China BEIJING, CHINA – November 20, 2012 – Medical Care Technologies Inc. (OTCBB: MDCE), a growing American company providing children’s healthcare services and western healthcare products distribution in China, released today the following letter to shar |
|
November 20, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 20, 2012 Medical Care Technologies Inc. |
|
November 19, 2012 |
Quarterly Report - QUARTERLY REPORT f10q0912medicalcare.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. |
|
November 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53665 CUSIP NUMBER 584507107 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended September 30, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tra |
|
October 17, 2012 |
MDCE / Medical Care Technologies Inc. / AGS CAPITAL GROUP LLC - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No *) MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.00001 Per Share (Title of Class of Securities) 584507107 (CUSIP Number) AGS Capital Group, LLC Attn: Allen Silberstein 801 Brickell Avenue, Suite 902 Miami, FL 33131 (305) 789-6641 (Name, Ad |
|
October 12, 2012 |
MEDICAL CARE TECHNOLOGIES INC. EXECUTIVE OFFICER EMPLOYMENT AGREEMENT EX-10.58 2 f8k100812ex10lviiimedical.htm EXECUTIVE OFFICER EMPLOYMENT AGREEMENT DATED OCTOBER 8, 2012 BETWEEN MEDICAL CARE TECHNOLOGIES INC. AND THOMAS J. (JOE) HALL II Exhibit 10.58 MEDICAL CARE TECHNOLOGIES INC. EXECUTIVE OFFICER EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement") is made between MEDICAL CARE TECHNOLOGIES INC. , a Nevada corporation (the "Company") located |
|
October 12, 2012 |
MDCE / Medical Care Technologies Inc. / AGS CAPITAL GROUP LLC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) COMMON STOCK, $0.00001 PER SHARE (Title of Class of Securities) 584507107 (CUSIP Number) April 5, 2012 (Date of Event Which Requires Filing of this Statement) CUSIP No. 584507107 Page 1 of 6 Pages 1 NAMES OF REPORTING PE |
|
October 12, 2012 |
Exhibit 99.1 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. ANNOUNCES DYNAMIC LEADERSHIP CHANGES IN THE LEAD UP TO THE OPENING OF ITS FIRST CHILDREN’S HEALTH CENTER IN CHINA -The right people in the right places…as the Shenzhen center moves closer to becoming China’s first, private, western-style pediatric health facility BEIJING, CHINA – October 12, 2012 – Medical Care Technologies Inc. (OT |
|
October 12, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 8, 2012 MEDICAL CARE TECHNOLOGIES INC. |
|
September 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC. |
|
September 21, 2012 |
EXHIBIT 10.56 Agreement Agreement, made as of April 23,2012 between Medical Care Technologies Inc. (the "Corporation"), and David Lubin, Esq. (the "Consultant"). Whereas, the Corporation wishes to issue the Consultant the number of shares of common stock provided for herein for services previously provided by the Consultant to the Corporation, and the Consultant is willing to accept the shares und |
|
September 21, 2012 |
BUSINESS ADVISORY & CONSULTING AGREEMENT EXHIBIT 10.54 BUSINESS ADVISORY & CONSULTING AGREEMENT This Agreement is entered into and with effective date the 1st day of April 2012 by and between Medical Care Technologies Inc. (the "Company") and Antoinette McMurray-Nelson (the "Consultant"), (hereinafter referred to collectively as the "Parties"). WHEREAS the Company desires to be assured of the association and services of the Consultant in |
|
September 21, 2012 |
ADMINISTRATIVE AND SUPPORT SERVICES AGREEMENT EXHIBIT 10.55 ADMINISTRATIVE AND SUPPORT SERVICES AGREEMENT This Administrative and Support Services Agreement is entered into by and between Margaret Yuen Yuen Chang (“Consultant”) with her headquarters in Hong Kong and Medical Care Technologies Inc., with its headquarters in Beijing, China (“Company”). RECITALS WHEREAS, the Consultant has the office premises and office staff required to provide |
|
September 21, 2012 |
NEW ENGINEERING SERVICES AGREEMENT EXHIBIT 10.57 NEW ENGINEERING SERVICES AGREEMENT THIS AGREEMENT made effective May 1st, 2012 (the "Effective Date"). BETWEEN: MEDICAL CARE TECHNOLOGIES INC., a body corporate, incorporated pursuant to the laws of the State of Nevada, U. S. A. (hereinafter referred to as the "Corporation") OF THE FIRST PART - and - BARRY P.N. TSAI, a resident of the city of Toronto, in the Province of Ontario, Cana |
|
September 21, 2012 |
EXHIBIT 3.1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
|
September 21, 2012 |
EXHIBIT 10.53 DG, CHINA NEW ADMINISTRATIVE SERVICES AGREEMENT (the "Agreement") dated as of April 1, 2012 between Medical Care Technologies Inc., a Nevada corporation ("MDCE") and Justin K. MOY ("JKMOY"), an individual. For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. Engagement. Upon the term |
|
September 21, 2012 |
EXHIBIT 4.2 |
|
September 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 12, 2012 MEDICAL CARE TECHNOLOGIES INC. |
|
August 17, 2012 |
Principal Amount: $35,000.00 Issue Date: August 13th , 2012 CONVERTIBLE PROMISSORY NOTE Exhibit 10.52 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
August 17, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as |
|
August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53665 NOTIFICATION OF LATE FILING CUSIP NUMBER 584507107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period EndedJune 30, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transitio |
|
July 30, 2012 |
Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2012 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES |
|
July 27, 2012 |
PURCHASE AND ASSIGNMENT AGREEMENT EXHIBIT 10.50 PURCHASE AND ASSIGNMENT AGREEMENT THIS PURCHASE AND ASSIGNMENT AGREEMENT (this “Agreement”), is entered into on July 17, 2012, by and between Barry Tsai (the “Assignor”) and Light Hammer, LLC (the “Assignee”). WHEREAS, Assignor is the legal and beneficial owner of that certain promissory note dated March 6, 2012, in the amount of $10,000 (the “Promissory Note”) and due on March 5, 20 |
|
July 27, 2012 |
EXHIBIT 10.49 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
July 27, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 12, 2012 MEDICAL CARE TECHNOLOGIES INC. |
|
July 27, 2012 |
EXHIBIT 10.48 SECURITIES SALE AGREEMENT THIS SECURITIES SALE AGREEMENT, dated as of July 17, 2012 (this "Agreement"), by and between Nicola SUPPA, an individual ("Buyer"), and Medical Care Technologies Inc., a Nevada corporation (“Seller”). Pursuant to and in reliance upon the exemption from registration by the Securities and Exchange Commission ("SEC") under the Securities Act of 1933, as amended |
|
July 27, 2012 |
EX-10.47 2 mdceex1047.htm LOAN AGREEMENT EXHIBIT 10.47 LOAN AGREEMENT THIS LOAN AGREEMENT, dated June 12th, 2012, made in Hong Kong, by and between: Party A: Ocean Wise International Industrial Limited, a Hong Kong incorporated company, with address at: 1301 Bank of America Tower, 12 Harcourt Road, Central Hong Kong. Party B: Medical Care Technologies Inc., a Nevada, USA incorporated company, with |
|
July 27, 2012 |
PURCHASE AND ASSIGNMENT AGREEMENT Exhibit 10.51 PURCHASE AND ASSIGNMENT AGREEMENT THIS PURCHASE AND ASSIGNMENT AGREEMENT (this “Agreement”), is entered into on July 17, 2012, by and between Boris Matsokhin (the “Assignor”) and Light Hammer, LLC (the “Assignee”). WHEREAS, Assignor is the legal and beneficial owner of that certain promissory note dated March 8, 2012, in the amount of $5,000 (the “Promissory Note”) and due on March 7 |
|
July 17, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 29, 2012 MEDICAL CARE TECHNOLOGIES INC. |
|
July 17, 2012 |
U.S. Securities and Exchange Commission EXHIBIT 10.37 U.S. Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20549 RE: Medical Care Technologies Inc. We agree with the Company’s statements regarding the discovery and reporting of errors in previously issued financial statements. We are also in agreement with management’s intentions regarding the restatements discussed in this Form 8-k. /s/ MaloneBailey, LLP www.ma |
|
July 17, 2012 |
EXHIBIT 10.45 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION |
|
July 17, 2012 |
MEDICAL CARE TECHNOLOGIES INC. Amended and Restated 10% Convertible Debenture Due November 29, 2014 EXHIBIT 10.46 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION |
|
July 17, 2012 |
EX-10.36 2 mdceex1036.htm IRREVOCABLE TRANSFER AGENT INSTRUCTIONS EXHIBIT 10.36 Medical Care Technologies Inc. Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China Website: www.medicaretechinc.com Tel: (8610) 6407 0580 May 29, 2012 Manhattan Transfer Registrar Co. 57 Eastwood Road Miller Place, NY 11764 Ladies and Gentlemen: MEDICAL CARE TECHNOLOGIES INC., a Nev |
|
May 25, 2012 |
MEDICAL CARE TECHNOLOGIES, INC. EXHIBIT 10.42 Exhibit A. MEDICAL CARE TECHNOLOGIES, INC. $25,000 TWELVE PERCENT (12%) CONVERTIBLE NOTE DATED MAY 21, 2012 THIS NOTE (the “Note”) is a duly authorized Convertible Note of MEDICAL CARE TECHNOLOGIES, INC., a NEVADA corporation (the “Company”). FOR VALUE RECEIVED, the Company promises to pay Atlas Equity Offshore, Ltd (the “Holder”), the principal sum of $25,000 (the “Principal Amount” |
|
May 25, 2012 |
ASSIGNMENT AND MODIFICATION AGREEMENT EXHIBIT 10.43 ASSIGNMENT AND MODIFICATION AGREEMENT This assignment and modification agreement (the "Agreement") is made by and among MEDICAL CARE TECHNOLOGIES, INC. (the "Issuer"), C. Wang (the "Non Affiliate Debtholder") and Atlas Equity Offshore, Ltd (the "Investor"), on May 21, 2012. (The Issuer, the Non Affiliate Debtholder and the Investor are sometimes referred to in this Agreement singly a |
|
May 25, 2012 |
MEDICAL CARE TECHNOLOGIES, INC. May 21, 2012 EX-10.44 4 mdceex1044.htm IRREVOCABLE TRANSFER AGENT INSTRUCTIONS FROM MEDICAL CARE TECHNOLOGIES, INC. TO MANHATTAN TRANSFER REGISTRAR CO. EXHIBIT 10.44 MEDICAL CARE TECHNOLOGIES, INC. May 21, 2012 Manhattan Transfer Registrar Co. 57 Eastwood Road Miller Place, NY 11764 Ladies and Gentlemen: MEDICAL CARE TECHNOLOGIES, INC., a NEVADA corporation (the "Company") and Atlas Equity Offshore, Ltd (the " |
|
May 25, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2012 MEDICAL CARE TECHNOLOGIES INC. |
|
May 24, 2012 |
Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q / A x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registra |
|
May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant a |
|
May 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2012 MEDICAL CARE TECHNOLOGIES INC. |
|
May 4, 2012 |
RESERVE EQUITY FINANCING AGREEMENT EXHIBIT 10.40 RESERVE EQUITY FINANCING AGREEMENT THIS AGREEMENT dated as of the 27th day of April 2012 (the “Agreement”) between AGS Capital Group, LLC (the “Investor”), and Medical Care Technologies, Inc. (the “Company”). WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Investor, from time to time as provided |
|
May 4, 2012 |
EXHIBIT 10.42 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT dated as of the 27 day of April 2012 (the “Agreement”) between AGS Capital Group, LLC (the “Investor”), and Medical Care Technologies, Inc. (the “Company”). WHEREAS: A. In connection with the Reserve Equity Financing Agreement by and between the parties hereto of even date herewith (the “ Reserve Equity Financing Agreem |
|
April 27, 2012 |
MEDICAL CARE TECHNOLOGIES INC. EXHIBIT 10.39 MEDICAL CARE TECHNOLOGIES INC. NING WU CEO AGREEMENT This Agreement is entered into as of April 23, 2012 by and between Medical Care Technologies Inc. (the “Company”) and Ning Wu (“CEO”). 1. Duties and Scope. (a) Positions and Duties. As of April 23, 2012 (the “Effective Date”), CEO will serve as President and Chief Executive Officer, reporting to the Company’s Board of Directors (th |
|
April 27, 2012 |
MEDICAL CARE TECHNOLOGIES INC. EXECUTIVE OFFICER EMPLOYMENT AGREEMENT EXHIBIT 10.37 MEDICAL CARE TECHNOLOGIES INC. EXECUTIVE OFFICER EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is made between MEDICAL CARE TECHNOLOGIES INC. , a Nevada corporation (the “Company”) located at Room 815, No. 2 Building, Beixiaojie, Dongzhimen Nei, Beijing 10009, and Luis Kuo, (the “Executive”) with address at Richmond Hill, Ontario, Canada, (collectively so |
|
April 27, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 23, 2012 MEDICAL CARE TECHNOLOGIES INC. |
|
April 27, 2012 |
SECOND AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENT EXHIBIT 10.38 SECOND AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENT This Second Amendment to Executive Officer Employment Agreement (this “2nd Amendment”) is made and entered into effective as of April 23, 2012 (“Effective Date”) by and between Medical Care Technologies Inc., a Nevada corporation (the “Company”) and the Company’s Chief Operations Officer, Luis KUO (the “COO” or “KUO”). RECITA |
|
April 16, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES |
|
April 16, 2012 |
Exhibit 99.2 Medical Care Technologies Inc. CEO Letter to Shareholders Dear Valued Shareholder, I write to you at an important and extraordinary time for Medical Care Technologies Inc. We have made significant progress in implementing our business strategy and navigating our way through China’s health care sector in 2011. Here are just some of our highlights of 2011: · Appointed highly experienced |
|
March 30, 2012 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 Commission File Number 000-53665 CUSIP Number: 584507107 NOTIFICATION OF LATE FILING (Check One): x Form 10-K o Form N-SAR o Form 20-F o Form N-CSR o Form 11-K o Form 10-Q o Form 10-D For Period Ended: December 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 10-Q o Transition Report on Form 20-F o Transition Report on Form N-SAR o Transition Report on Form 11-K For the Transition Period Ended: Read instruction (on back page) before preparing form. |
|
March 30, 2012 |
Exhibit 3.3 ROSS MILLER Secretary of State 204 North Carson Street, Suite 1 Carson City, Nevada 89701-4520 (775) 684-5708 Website: www.nvsos.gov *090201* Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) USE BLACK INK ONLY - DO NOT HIGHLIGHTABOVE SPACE IS FOR OFFICE USE ONLY Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporations (Pursuant to NRS 78.385 and |
|
March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report(Date of earliest event reported) March 29, 2012 Medical Care Technologies, Inc. |
|
February 6, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
January 24, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of |
|
December 15, 2011 |
MEDICAL CARE TECHNOLOGIES INC. Amended and Restated 15% Convertible Debenture Due December 9, 2013 Exhibit4.13 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION S |
|
December 15, 2011 |
Exhibit 10.35 STOCK ESCROW AGREEMENT This Stock Escrow Agreement (this "Agreement") is made and entered into as of November , 2011 by and among between Long Side Ventures LLC, a Florida limited liability company ("Investor") Medical Care Technologies., Inc. (the “Company”), and Jonathan D. Leinwand, P.A. ("Escrow Agent"). Capitalized terms used herein but not otherwise defined shall have the meani |
|
December 15, 2011 |
Exhibit 10.34 DEBT PURCHASE AGREEMENT THIS AGREEMENTis made as of the 8 day of December, 2011 AMONG: LONG SIDE VENTURES LLC., a Florida limited liability company having an office for business located at 1800 S. Ocean Dr., PH2 , Hallandale Beach, Florida 33009(?Purchaser?) AND: CELINE WANG, an individual with an address 8 Gough Rd, The Peak, Hong Kong, (?Seller?) WHEREAS: A. Seller holds a certain |
|
December 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 9, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
December 15, 2011 |
IRREVOCABLE TRANSFER AGENT INSTRUCTIONS Exhibit 10.36 IRREVOCABLE TRANSFER AGENT INSTRUCTIONS December 15, 2011 Empire Stock Transfer Inc. 1859 Whitney Mesa Dr. Henderson, NV, 89014 RE: Medical Care Technologies Inc. Ladies and Gentlemen: Reference is made to that certain Convertible Debenture (the "Convertible Debenture"), dated the date hereof, by and between Medical Care Technologies, Inc., a corporation organized under the laws of N |
|
November 17, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registra |
|
November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53665 CUSIP NUMBER 584507107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2011 o Tra |
|
October 28, 2011 |
FILED PURSUANT TO RULE 424(B)(3) REGISTRATION NO. 333-177245 FILED PURSUANT TO RULE 424(B)(3) REGISTRATION NO. 333-177245 MEDICAL CARE TECHNOLOGIES INC. Shares of Common Stock We are offering up to 60,000,000 shares at a price per share of $0.01 on a best efforts basis. We are making this offering without the involvement of underwriters or broker-dealers. The shares of our common stock to be sold by us will be sold on our behalf by our executive officers an |
|
October 24, 2011 |
As filed with the Securities and Exchange Commission on October 24, 2011 Registration No. |
|
October 11, 2011 |
MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT Exhibit 10.30 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide |
|
October 11, 2011 |
Exhibit 10.1 LETTER OF INTENT Parties: AM Oil Resources & Technology Inc., a Nevada corporation ("AM Oil"), and Great Union Corporation, a Hong Kong corporation ("Great Union"), wish to enter into this letter of intent (the "LOI") which will provide for the basic structure of a share exchange and reverse merger between the parties (the "Share Exchange"). It is the intention of the parties to enter |
|
October 11, 2011 |
As filed with the Securities and Exchange Commission on October 11, 2011 Registration No. |
|
October 11, 2011 |
Exhibit 10.2 ASSET ACQUISITION AGREEMENT THIS AGREEMENT is made effective as of the 9th day of January, 2010 AMONGST: MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, having an office at 22 Notting Hill Gate, Suite 127, London, UK, X0 W11 3JE (the ?Purchaser?) AND: GREAT UNION CORPORATION a Hong Kong corporation, having an office at Room 25, Block A, 19th Floor, Wah Lok Industrial Court, 31-4 |
|
October 11, 2011 |
EXHIBIT 21.1 SUBSIDIARIES ReachOut Holdings Limited (Hong Kong) ? 65% ownership |
|
October 11, 2011 |
MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT Exhibit 10.28 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide |
|
October 11, 2011 |
MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT Exhibit 10.32 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide |
|
October 11, 2011 |
MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT Exhibit 10.33 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 1st day of February, 2011, the date this Option was granted pursuant to the Plan. This Option provides |
|
October 11, 2011 |
MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT Exhibit 10.29 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide |
|
October 11, 2011 |
MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT Exhibit 10.31 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this 30th day of December, 2010, the date this Option was granted pursuant to the Plan. This Option provide |
|
September 28, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment1) MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Shares of Common Stock, $0.00001 Par Value (Title of Class of Securities) 584507107 (CUSIP Number) Ning C. Wu, CEO Room 815, No. 2 Building Beixiaojie Dongzhimen Nei, Beijing 10009 People?s Republic of China Tel |
|
September 28, 2011 |
Exhibit 3 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this “Agreement”) dated as of September 19, 2011 between Ning Wu (the “Seller”) and (the “Purchaser”). |
|
September 28, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 19, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
September 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 9, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
September 15, 2011 |
Principal Amount: $45,000.00 Issue Date: September 9, 2011 Exhibit 4.93 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
September 15, 2011 |
Exhibit 10.23 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 9, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, DongzhimenNei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its |
|
August 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as |
|
August 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: November 30, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53665 CUSIP NUMBER 584507107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 3 |
|
August 10, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 4, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
August 10, 2011 |
FIRST AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENT Exhibit 10.22 FIRST AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENT This First Amendment to Executive Officer Employment Agreement (this ?1st Amendment?) is made and entered into effective as of August 1, 2011 (?Effective Date?) by and between Medical Care Technologies Inc., a Nevada corporation (the ?Company?) and the Company?s Chief Operations Officer, Luis KUO (the ?COO? or ?KUO?). RECITALS |
|
July 28, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 20, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
July 28, 2011 |
Exhibit 10.21 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 20, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its add |
|
July 28, 2011 |
EXHIBIT 4.92 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
June 28, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant |
|
June 27, 2011 |
CORRESP 1 filename1.htm MEDICAL CARE TECHNOLOGIES, INC. Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei Beijing, China 10009 Via EDGAR June 27, 2011 Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.W. Washington, D.C. 20549-0406 Attention: Ernest Greene Re: Medical Care Technologies, Inc. Form 10-K/A for the year ended December 31, 2010 Form 10-Q/A for the perio |
|
June 27, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2010 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLO |
|
June 27, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A (Amendment No. 2) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDIC |
|
June 27, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2010 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES, |
|
June 9, 2011 |
NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
June 9, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 21, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
June 9, 2011 |
Exhibit 10.20 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 1, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its addr |
|
June 2, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC. |
|
June 2, 2011 |
AGREEMENT ARTICLE I RELATIONSHIP OF THE PARTIES Exhibit 99.1 THIS MANAGEMENT SERVICES AGREEMENT (the "Agreement") is entered into as of April 1, 2011 (the "Effective Date") by and between Medical Care Technologies Inc., a Nevada corporation ("MDCE"), and LOW Sze Man, an individual experienced in business and administrative management in the People’s Republic of China (the "Management Person"). RECITALS - A. MDCE, through its Hong Kong and Chine |
|
June 2, 2011 |
Exhibit 99.3 AGREEMENT FOR MANAGEMENT ADVISORY SERVICES THIS MANAGEMENT ADVISORY SERVICES AGREEMENT (this "Agreement") is made as of May 10, 2011, between Medical Care Technologies Inc., a Nevada corporation (the "Company"), and YIU Chung Han, an individual and business manager ("Advisor"). WHEREAS, the Company and Advisor are entering into this Agreement pursuant to that certain Joint Venture Mas |
|
June 2, 2011 |
AGREEMENT FOR CONSULTING SERVICES Exhibit 99.4 AGREEMENT FOR CONSULTING SERVICES AGREEMENT made and entered into as of this 16th of May 2011 (the "Agreement"), by and between Medical Care Technologies Inc. (the ?Company?) located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing 10009 and Nicola Suppa (?the Consultant?), located at 1035 Country Club Dive, Suite 206, Margate FL 33063. RECITALS WHEREAS, the Consultant |
|
June 2, 2011 |
Exhibit 99.2 ADMINISTRATIVE SERVICES (the "Agreement") dated as of April 1, 2011 between Medical Care Technologies Inc., a Nevada corporation ("MDCE") and LIEW Kit Ha ("LIEW"), an individual. For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. Engagement. Upon the terms and subject to the conditi |
|
June 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of regist |
|
June 1, 2011 |
ACCREDITED MEMBERS, INC. ANNUAL PROFILE AGREEMENT Exhibit 10.6 ACCREDITED MEMBERS, INC. ANNUAL PROFILE AGREEMENT This Annual Profile Agreement is entered into between Medical Care Technologies, Inc. (“Customer”) located at #888-33 Hazelton Ave., Toronto, ONM5R 2E3 and Accredited Members, Inc. (“AMI”). This Agreement, along with the Accredited Members, Inc. Terms and Conditions (the “Terms and Conditions”) governs the terms and conditions upon whi |
|
June 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGI |
|
June 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registr |
|
May 31, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
May 23, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant a |
|
May 17, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53665 CUSIP NUMBER 584507107 NOTIFICATION OF LATE FILING (Check one): o Form 10-K oForm 20-F o Form 11-K x Form 10-Q o Form 10-D oForm N-SAR o Form N-CSR For Period Ended March 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transitio |
|
May 6, 2011 |
Exhibit 4.9 CONVERTIBLE PROMISSORY NOTE THIS NOTE AND ANY SHARES OF STOCK ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THIS NOTE AND ANY SHARES OF STOCK ISSUABLE UPON THE CONVERSION HEREOF MAY NOT BE SOLD, OFFERED FOR SALE, OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMEN |
|
May 6, 2011 |
Exhibit 10.19 Dated the 28th day of April, 2011 Medical Care Technologies Inc. and Ocean Wise International Industrial Limited JOINT-VENTURE MASTER AGREEMENT Table of Contents Chapter 1. General 3 2. Parties 3 3. Establishment of Joint Venture Company 3 4. Purposes, Scope and Scale of Business 4 5. Total Amount of Investment and Registered Capital 4 6. Responsibilities of the Parties 6 7. Doing Bu |
|
May 6, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 28, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
April 22, 2011 |
Exhibit 10.14 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 12, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its ad |
|
April 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 21, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
April 22, 2011 |
Principal Amount: $32,500.00 Issue Date: April 12, 2011 Purchase Price: $32,500.00 Exhibit 4.8 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
April 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: November 30, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53665 CUSIP NUMBER (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 201 |
|
April 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES |
|
March 24, 2011 |
Exhibit 10.13 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 11, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its ad |
|
March 24, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 21, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
March 24, 2011 |
Exhibit 4.7 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
February 16, 2011 |
EX-10.12 3 f8k020111ex10xiimedcaretech.htm SECURITIES PURCHASE AGREEMENT Exhibit 10.12 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 1, 2011, by and between MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation, with headquarters located at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing, People's Republic of China 10009 (the “ |
|
February 16, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 1, 2011 MEDICAL CARE TECHNOLOGIES INC. |
|
February 16, 2011 |
Principal Amount: $50,000.00 Issue Date: February 1, 2011 Purchase Price: $50,000.00 Exhibit 4.6 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
January 5, 2011 |
English Translation Contractor Agreement Exhibit 10.11 Consulting and Custom Software Development & Upgrade English Translation Contractor Agreement This Agreement is effective as of the date of the party last signing below by and between MEDICAL CARE TECHNOLOGIES INC. (the ?Company?), with offices at Room 815, No. 2 Building, Beixiaojie, Dongzhimen Nei, Beijing, China 10009, and L. Eddison Parke, Information Technology Technicians & Con |
|
January 5, 2011 |
ADMINISTRATIVE SERVICES AGREEMENT Exhibit 10.7 ADMINISTRATIVE SERVICES AGREEMENT ADMINISTRATIVE SERVICES (the "Agreement") dated as of August 31, 2010 between KAREN A. VINCENT, an individual ("VINCENT") and MEDICAL CARE TECHNOLOGIES, INC., a Nevada corporation ("Medical Care"). For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. |
|
January 5, 2011 |
MEDICAL CARE TECHOLOGIES INC. 2010 STOCK OPTION PLAN Exhibit 4.3 MEDICAL CARE TECHOLOGIES INC. 2010 STOCK OPTION PLAN Section 1. Establishment and Purpose. The name of the plan is the Medical Care Technologies Inc. 2010 Stock Option Plan (the "Plan"). The purpose of the Plan is to provide key employees, officers, directors, consultants and agents of Medical Care Technologies Inc. and its subsidiaries (the "Company") added incentive for high levels o |
|
January 5, 2011 |
MEDICAL CARE TECHNOLOGIES, INC. BUSINESS ADVISORY & CONSULTING AGREEMENT Exhibit 10.10 MEDICAL CARE TECHNOLOGIES, INC. BUSINESS ADVISORY & CONSULTING AGREEMENT AGREEMENT made as of the 1st day of October, 2010 ( the “Effective Date”), by and between Shu Zhen Bei (“Consultant”), and Medical Care Technologies, Inc. (hereafter referred to as “MDCE”) having a place of business at Room 815, No. 2 Building Beixiaojie, Dongzhimen Nei, Beijing 10009. WHEREAS, The Company has e |
|
January 5, 2011 |
ADMINISTRATIVE SERVICES AGREEMENT Exhibit 10.9 ADMINISTRATIVE SERVICES AGREEMENT ADMINISTRATIVE SERVICES (the "Agreement") dated as of November 15, 2010 between GRETTA MOY, an individual ("MOY") and Medical Care Technologies Inc., a Nevada corporation ("Medical Care"). For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. Engagemen |
|
January 5, 2011 |
ADMINISTRATIVE SERVICES AGREEMENT Exhibit 10.8 ADMINISTRATIVE SERVICES AGREEMENT ADMINISTRATIVE SERVICES (the "Agreement") dated as of September 2, 2010 between ANNA TANG, an individual ("TANG") and MEDICAL CARE TECHNOLOGIES, INC., a Nevada corporation ("Medical Care"). For good and valuable consideration, the receipt and legal sufficiency of which are hereby expressly acknowledged, the parties hereto agree as follows: 1. Engageme |
|
January 5, 2011 |
MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT Exhibit 4.4 MEDICAL CARE TECHOLOGIES INC. STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Option?) is granted to the Optionee named above by Medical Care Technologies Inc. (the ?Corporation?) pursuant to the Medical Care Technologies Inc. 2010 Stock Option Plan (the ?Plan?) as of this day of , 201, the date this Option was granted pursuant to the Plan. This Option provides you an option |
|
January 5, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDICAL CARE TECHNOLOGIES INC. |
|
December 28, 2010 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (Rule 14C-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) Of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d) (1)) x Definitive Information Statement MEDI |
|
December 7, 2010 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C (Rule 14C-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) Of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d) (1)) o Definitive Information Statement MEDI |
|
November 19, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registra |
|
November 19, 2010 |
ACCREDITED MEMBERS, INC. ANNUAL PROFILE AGREEMENT Exhibit 10.6 ACCREDITED MEMBERS, INC. ANNUAL PROFILE AGREEMENT This Annual Profile Agreement is entered into between Medical Care Technologies, Inc. (?Customer?) located at #888-33 Hazelton Ave., Toronto, ONM5R 2E3 and Accredited Members, Inc. (?AMI?). This Agreement, along with the Accredited Members, Inc. Terms and Conditions (the ?Terms and Conditions?) governs the terms and conditions upon whi |
|
November 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: November 30, 2012 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53665 CUSIP NUMBER 584507107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: Septemb |
|
October 12, 2010 |
Exhibit 7.1 CEO AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT, dated as of September 13, 2010 (hereafter, the ?Amendment Agreement?), is entered into between Medical Care Technologies Inc., a Nevada corporation, (hereafter, the ?Company?), and Ning C. Wu, an individual (hereafter, the ?Management Consultant?). WHEREAS, the Company and the Management Consultant had entered into a consultancy agreeme |
|
October 12, 2010 |
Exhibit 7.2 Lock-Up Agreement THIS LOCK-UP AGREEMENT (this “Agreement”) is entered into as of September 13, 2010 between Ning Wu (“Wu”) and MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation (the “Company”). WHEREAS, Wu holds 38,000,000 restricted common stock of the Company, par value $0.00001 (the “Company Common Stock”); WHEREAS, the Company believes it is in the best interests of its stockho |
|
October 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment) MEDICAL CARE TECHNOLOGIES, INC. (Name of Issuer) Shares of Common Stock, $0.00001 Par Value (Title of Class of Securities) 584507107 (CUSIP Number) Ning C. Wu, CEO Room 815, No. 2 Building Beixiaojie Dongzhimen Nei, Beijing 10009 People?s Republic of China Tele |
|
September 20, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 13, 2010 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Nevada 000-53665 N/A (State or other jurisdiction of incorporation) (Commission |
|
September 20, 2010 |
MEDICAL CARE TECHNOLOGIES INC. NING WU CONSULTANCY AGREEMENT Exhibit 10.5 MEDICAL CARE TECHNOLOGIES INC. NING WU CONSULTANCY AGREEMENT This Agreement is entered into as of November 25, 2009 by and between Medical Care Technologies Inc. (the “Company”) and Ning Wu (“Consultant”). 1. Duties and Scope of Consultancy. (a) Positions and Duties. As of November 25, 2009 (the “Effective Date”), Consultant will serve as President and Chief Executive Officer, reporti |
|
September 20, 2010 |
Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) Exhibit 99.1 ROSS MILLER Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89701-4069 (775) 684-5708 Website: www.nvsos.gov Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) USE BLACK INK ONLY ? DO NOT HIGHLIGHT ABOVE SPACE FOR OFFICE USE ONLY Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporation Pursuant to NRS 78.385 and 78.390 - (Afte |
|
September 20, 2010 |
Exhibit 10.3 CEO AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT, dated as of September 13, 2010 (hereafter, the ?Amendment Agreement?), is entered into between Medical Care Technologies Inc., a Nevada corporation, (hereafter, the ?Company?), and Ning C. Wu, an individual (hereafter, the ?Management Consultant?). WHEREAS, the Company and the Management Consultant had entered into a consultancy agreem |
|
September 20, 2010 |
Exhibit 10.4 Lock-Up Agreement THIS LOCK-UP AGREEMENT (this “Agreement”) is entered into as of September 13, 2010 between Ning Wu (“Wu”) and MEDICAL CARE TECHNOLOGIES INC., a Nevada corporation (the “Company”). WHEREAS, Wu holds 38,000,000 restricted common stock of the Company, par value $0.00001 (the “Company Common Stock”); WHEREAS, the Company believes it is in the best interests of its stockh |
|
September 7, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 1, 2010 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Nevada 000-53665 N/A (State or other jurisdiction of incorporation) (Commission |
|
August 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registran |
|
May 24, 2010 |
Medical Care Technologies Inc. - Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file |
|
May 18, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-53665 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2010 [ ] |
|
May 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 10, 2010 MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Nevada 000-53665 N/A (State or other jurisdiction of (Commission File Number) (IRS Em |
|
April 12, 2010 |
Medical Care Technologies Inc.: Form 10-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition |
|
April 9, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 AM OIL RESOURCES & TECHNOLOGY INC. (Ex |
|
April 9, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 AM OIL RESOURCES & TECHNOLOGY INC. (Exa |
|
April 1, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-53665 [ x ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2009 |
|
February 11, 2010 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only [as permitted by Rule 14a-6(e)(2)] [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material Pursuant to Section 240. |
|
January 22, 2010 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only [as permitted by Rule 14a-6(e)(2)] [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material Pursuant to Section 240. |
|
January 20, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 20, 2010 (January 20, 2010) MEDICAL CARE TEHCNOLOGIES INC. (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdiction of incorporation |
|
January 14, 2010 |
MEDICAL CARE TECHNOLOGIES INC. APPOINTS KEY MEMBER TO ITS ADVISORY BOARD Exhibit 99.1 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. APPOINTS KEY MEMBER TO ITS ADVISORY BOARD LONDON, ENGLAND – January 11, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) today announced that Minh Nguyen was elected as an Advisory Board Member to the Company. Ms. Nguyen brings extensive knowledge of business, as well as experience in several industries, including international b |
|
January 14, 2010 |
MEDICAL CARE TECHNOLOGIES INC. COMMENCES TRIALS FOR CONTINUOUS GLUCOSE MONITORING AS ADD-ON Exhibit 99.5 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. COMMENCES TRIALS FOR CONTINUOUS GLUCOSE MONITORING AS ADD-ON LONDON, ENGLAND – January 13, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) today announced that it has commenced trials to include Continuous Glucose Monitoring (CGM) to its current Tele-Health™ Suite. Management believes that by adding this function to its Tele-Hea |
|
January 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 14, 2010 (January 9, 2010) MEDICAL CARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdiction of incorporation) |
|
January 14, 2010 |
Exhibit 99.4 Medical Care Technologies Inc. Completes International Secure Practice Management Suite for Testing in China LONDON, ENGLAND ? January 12, 2010 ? Medical Care Technologies Inc. (OTCBB: MDCE) announces the completion of a secure practice management system for medical clinics in China. The deployment of our MedSuite technology will allow the first test site in Hebei Province to institut |
|
January 14, 2010 |
MEDICAL CARE TECHNOLOGIES INC. ANNOUNCES APPOINTMENT OF NEW CEO Exhibit 99.3 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. ANNOUNCES APPOINTMENT OF NEW CEO LONDON, ENGLAND – January 12, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) today announced that Ning C. Wu has joined MDCE as its new President, Chief Executive Officer, and Chief Financial Officer effective immediately. Ms. Wu is a seasoned entrepreneur with over 25 years experience in both t |
|
January 14, 2010 |
Medical Care Technologies Inc. Secures Financing Exhibit 99.6 FOR IMMEDIATE RELEASE Medical Care Technologies Inc. Secures Financing LONDON, ENGLAND ? January 13, 2010 ? Medical Care Technologies Inc. (OTCBB: MDCE) announces that it has completed a non-brokered private placement of 500,000 units at a price of US$0.20 per unit for total proceeds of US$100,000. Each unit purchased is of one share of common stock, and one Series A Warrant. Each Ser |
|
January 14, 2010 |
MEDICAL CARE TECHNOLOGIES INC. SIGNS ASSET ACQUISITION AGREEMENT Exhibit 99.2 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. SIGNS ASSET ACQUISITION AGREEMENT LONDON, ENGLAND – January 11, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) today announced that it has reached a definitive agreement to acquire various technologies from Great Union Corporation, (“GUC”) a private Hong Kong corporation. The Boards of Directors of both companies have unanimous |
|
January 11, 2010 |
MEDICAL CARE TECHNOLOGIES INC. PROVIDES CORPORATE UPDATE Exhibit 99.1 FOR IMMEDIATE RELEASE MEDICAL CARE TECHNOLOGIES INC. PROVIDES CORPORATE UPDATE LONDON, ENGLAND – January 8, 2010 – Medical Care Technologies Inc. (OTCBB: MDCE) would like to provide its shareholders with a corporate update. On October 6, 2009, MDCE entered into a non-binding Letter of Intent with Great Union Corporation, (“GUC”) a Hong Kong corporation, with the intent to acquire owne |
|
January 11, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: January 8, 2010 Commission File Number: 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact Name of Registrant as Specified in Charter) NEVADA (state or other jurisdiction of incorporation or organization) 22 Notting Hill |
|
November 23, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 MEDICAL CARE TECHNOLOGIES, INC. (Formerly AM Oil R |
|
November 20, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: November 20, 2009 Commission File Number: 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact Name of Registrant as Specified in Charter) NEVADA (state or other jurisdiction of incorporation or organization) 22 Notting Hi |
|
November 17, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For the period ended September 30, 2009 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q For the |
|
October 20, 2009 |
Exhibit 2.1 |
|
October 20, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: October 13, 2009 Commission File Number: 000-53665 MEDICAL CARE TECHNOLOGIES INC. (Exact Name of Registrant as Specified in Charter) NEVADA (state or other jurisdiction of incorporation or organization) 22 Notting Hil |
|
October 1, 2009 |
8-K 1 amoil8k092809.htm AM OIL RESOURCES & TECHNOLOGY INC. FORM 8-K FOR SEPTEMBER 28, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 28, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) |
|
August 14, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 AM OIL RESOURCES & TECHNOLOGY INC. (Exact name of regis |
|
July 22, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 20, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdi |
|
July 16, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 7, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdic |
|
July 9, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 7, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdic |
|
June 30, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 29, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdi |
|
June 17, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-53665 AM OIL RESOURCES & TECHNOLOGY INC. (Exact name of regi |
|
May 22, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 11, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 000-53665 (State or other jurisdic |
|
May 18, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For the period ended March 31, 2009 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q For the Tran |
|
May 7, 2009 |
AM Oil Resources & Technology Inc. Form 8-A SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) or (g) OF THE SECURITIES EXCHANGE ACT OF 1934 AM OIL RESOURCES & TECHNOLOGY INC. (Exact name of registrant as specified in its charter.) Nevada (State of incorporation of organization) 27240 Turnberry Lane, Suite |
|
April 15, 2009 |
AM OIL RESOURCES & TECHNOLOGY INC. CODE OF ETHICS TOPICS Code of Ethics Exhibit 14.1 AM OIL RESOURCES & TECHNOLOGY INC. CODE OF ETHICS TOPICS 1. Statement of Policy 2. Implementation and Enforcement 3. Relations with Competitors and Other Third Parties 4. Insider Trading, Securities Compliance and Public Statements 5. Financial Reporting 6. Human Resources 7. Environmental, Health and Safety 8. Conflicts of Interest 9. International Trade 10. Government |
|
April 15, 2009 |
Exhibit 10.1 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (this ?Agreement?), dated November 25, 2008, is made between AM Oil Resources & Technology Inc., residing in the State of California (?Sellers?) and Aventerra Explorations, Inc., a Nevada corporation (the ? Buyer ?). RECITALS WHEREAS, the Buyer desires to acquire from the Sellers, the assets listed on ?Exhibit A? attached hereto ( |
|
April 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 Commission file number 333-151332 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) Nevada (State or oth |
|
April 15, 2009 |
AM OIL RESOURCES & TECHNOLOGY INC. CHARTER - AUDIT COMMITTEE Committee Role Exhibit 99.1 AM OIL RESOURCES & TECHNOLOGY INC. CHARTER - AUDIT COMMITTEE Committee Role The committee's role is to act on behalf of the board of directors and oversee all material aspects of the company's reporting, control, and audit functions, except those specifically related to the responsibilities of another standing committee of the board. The audit committee's role includes a particular fo |
|
April 15, 2009 |
Exhibit 10.2 AMENDMENT TO AGREEMENT AMENDMENT TO AGREEMENT dated November 25, 2008, between AM Oil Resources & Technology, Inc. formerly Aventerra Explorations, Inc. hereinafter collectively referred to as ?Buyer? and AM Oil Resources & Technology Inc., a California corporation, hereinafter collectively referred to as "Seller?. WHEREAS, the parties desire to amended the agreement entered into betw |
|
April 15, 2009 |
AM OIL RESOURCES & TECHNOLOGY INC. DISCLOSURE COMMITTEE CHARTER Exhibit 99.2 AM OIL RESOURCES & TECHNOLOGY INC. DISCLOSURE COMMITTEE CHARTER Disclosure Policy All financial disclosures made by the Corporation to its security holders or the investment community should (i) be accurate, complete and timely, (ii) fairly present, in all material respects, the Corporation's financial condition, results of operations and cash flows, and (iii) meet any other legal, re |
|
April 1, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For the period ended December 31, 2008. [ ] Transition Report on Form 10-K. [ ] Transition Report on Form 20-F. [ ] Transition Report on Form 11-K. [ ] Transition Report on Form 10-Q. For |
|
March 2, 2009 |
AM Oil Resources & Technology Inc. Form 8K for November 25, 2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 25, 2008 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant |
|
February 2, 2009 |
AM Oil Resources & Technology Outlines Goal for 2009 Exhibit 99.1 AM Oil Resources & Technology Outlines Goal for 2009 VALENCIA, CALIFORNIA, January 30, 2009 (BUSINESSWIRE) ? AM Oil Resources & Technology Inc., (OTCBB: AMOR.OB) announced today that it intends to build approximately 20 of its patented MT-06 Portable Steam Systems in 2009. As previously stated, each Portable Steam Systems used by the Company is capable of producing from $2-$6 million |
|
February 2, 2009 |
AM Oil Resources & Technology Inc. Form 8-K for 01-30-2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 30, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as spec |
|
January 29, 2009 |
AM Oil Resources & Technology to Seek Product Exposure Through Media Outlets Exhibit 99.1 AM Oil Resources & Technology to Seek Product Exposure Through Media Outlets VALENCIA, CALIFORNIA, January 28, 2009 (BUSINESSWIRE) ? AM Oil Resources & Technology Inc., (OTCBB: AMOR) announced today that the Company has adopted a strategy of pursuing air time and space on print and media outlets to increase awareness of its patented products and technologies for maximizing crude oil r |
|
January 29, 2009 |
AM Oil Resources & Technology Acquires Build Biodiesel Technology to Create Energy Diversity Exhibit 99.1 AM Oil Resources & Technology Acquires Build Biodiesel Technology to Create Energy Diversity VALENCIA, CALIFORNIA, January 26, 2009 (BUSINESSWIRE) ? AM Oil Resources & Technology Inc., (OTCBB: AMOR.OB) announced today that it has just completed design drawings to build a mobile bio-diesel device. The Company?s design is a mobile biodiesel production plant, capable of producing 2,000 t |
|
January 29, 2009 |
AM Oil Resources & Technology Inc. Form 8-K for January 28, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 28, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant a |
|
January 29, 2009 |
AM Oil Resources & Technology Inc. Form 8-K for January 26, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 26, 2009 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant a |
|
January 26, 2009 |
AM Oil Resources & Technology New Company Brochure Available on the Company’s Website Exhibit 99.1 AM Oil Resources & Technology New Company Brochure Available on the Company?s Website VALENCIA, CALIFORNIA, January 23, 2009 (BUSINESSWIRE) ? AM Oil Resources & Technology Inc., (OTC:BB: AMOR.OB) announce today that it has created a new company brochure to provide the public and its current shareholders with additional detailed information related to the Company and the oil and gas ma |
|
January 26, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 23, 2009 - (January 23, 2009) AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 333-15133 |
|
December 24, 2008 |
Exhibit 99.1 AM Oil Resources & Technology Inc. Announces New Direction for the Company and Appoints New Directors VALENCIA, Calif.-(BUSINESS WIRE)- AM Oil Resources & Technology Inc., (OTCBB:AXPI) today announced that the Officers and Directors have begun to chart a new course for the Company. Since inception, the prior company was involved in the mining business with properties held for explorat |
|
December 24, 2008 |
AM Oil Resources & Technology Inc. Form 8-K for December 24, 2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 24, 2008 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant |
|
December 22, 2008 |
AM Oil Resources & Technology Inc. Philip Morgan 800-646-6570 [email protected] www.am-oil.com Exhibit 99.1 AM Oil Resources & Technology Inc., Formerly Known as Aventerra Exploration, Inc., Announces the Acquisition of Patented Oil Recovery Technology VALENCIA, Calif.- December 22, 2008 - (BUSINESS WIRE)- AM Oil Resources & Technology Inc. (OTCBB: AXPI) announced that the Company has acquired two patents from AM Oil Resources & Technology Inc., a California corporation ("AM Oil"). The Comp |
|
December 22, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 3, 2008 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 333-151332 (State or other jur |
|
December 22, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 22, 2008 AM OIL RESOURCES & TECHNOLOGY INC. (Formerly Aventerra Explorations, Inc.) (Exact name of registrant as specified in its charter) NEVADA 333-151332 (State or other ju |
|
December 22, 2008 |
AM Oil Resources & Technology Inc. Exhibit 3.3 Exhibit 3.3 ROSS MILLER Filed in the office of Document Number Secretary of State ROSS MILLER 20080787612-41 [SEAL] 204 North Carson Street, Ste 1 Ross Miller Filing Date and Time Carson City, Nevada 89701-4299 Secretary of State 12/03/2008 3:40 PM (775) 684 5708 State of Nevada Entity Number Website: nvsos.gov E0136282007-6 Certificate of Amendment ( |
|
December 1, 2008 |
Aventerra Explorations, Inc. Form 8-K for November 25, 2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 25, 2008 AVENTERRA EXPLORATIONS, INC. (Formerly Ridgestone Resources, Inc.) (Exact name of registrant as specified |
|
November 18, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A-1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A-1 [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 333-151332 AVENTERRA EXPLORATIONS, INC. (Exact name of r |
|
November 13, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 333-151332 AVENTERRA EXPLORATIONS, INC. (Exact name of regis |
|
August 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2008 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 333-151332 AVENTERRA EXPLORATIONS, INC. (Exact name of registrant |
|
May 30, 2008 |
SUBSIDIARIES OF THE REGISTRANT Exhibit 21.1 - Subsidiaries of the Registrant Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Aventerra Explorations Ltd. |
|
May 30, 2008 |
BYLAWS OF AVENTERRA EXPLORATIONS, INC. Exhibit 3.2 BYLAWS OF AVENTERRA EXPLORATIONS, INC. I. SHAREHOLDER'S MEETING. .01 Annual Meetings. The annual meeting of the shareholders of this Corporation, for the purpose of election of Directors and for such other business as may come before it, shall be held at the registered office of the Corporation, or such other places, either within or without the State of Nevada, as may be designated by |
|
May 30, 2008 |
AVENTERRA EXPLORATIONS, INC. ADDITIONAL ARTICLES Exhibit 3.1 - Articles of Incorporation Exhibit 3.1 ROSS MILLER Filed in the office of Document Number Secretary of State ROSS MILLER 20070135931-71 [SEAL] 206 North Carson Street Ross Miller Filing Date and Time Carson City, Nevada 89701-4299 Secretary of State 2/27/2007 12:20PM (775) 684 5708 State of Nevada Entity Number Website: secretaryofstate.biz E0136282007-6 Articles of Incorporation (PUR |
|
May 30, 2008 |
aventerras-1.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVENTERRA EXPLORATIONS, INC. (Name of small business issuer in its charter) Nevada (State or Other Jurisdiction of Organization) AVENTERRA EXPLORATIONS, INC. 2 |
|
May 30, 2008 |
Exhibit 4.1 - Specimen Stock Certificate Exhibit 4.1 Number Shares AVENTERRA EXPLORATIONS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA 100,000,000 SHARES COMMON STOCK AUTHORIZED, $0.00001 PAR VALUE CUSIP SEE REVERSE FOR This CERTAIN certifies DEFINITIONS that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF AVENTERRA EXPLORATIONS, INC. transferable on the books o |